Have You Heard?

News and Updates from Child Neurology Foundation

FYCOMPA® (perampanel) Oral Suspension Now Available as an Option for Patients with Epilepsy Who May Have Difficulty Swallowing Tablets or Prefer Liquids

Posted on:

Eisai Inc. announced today the availability of FYCOMPA® (perampanel) Oral Suspension, a new bioequivalent interchangeable alternative to the FYCOMPA tablet for patients who have difficulty swallowing tablets or prefer liquids. FYCOMPA CIII is indicated as adjunctive therapy for the treatment of partial-onset seizures (POS) with or without secondarily generalized seizures,…  Read More

ANNOUNCING New CURE Program: Post-Traumatic Epilepsy Initiative

Posted on:

In collaboration with the U.S. Department of Defense, CURE is excited to launch a NEW research program to support a collaborative, milestone-driven approach to advance the understanding of epilepsy as a result of traumatic brain injury. Webinar/conference call* June 9, 2016 – 12pm ET June 22, 2016 – 4pm ET…  Read More

Partners Against Mortality in Epilepsy Conference

Posted on:

DATES: Thursday June 23 – Sunday, June 26 LOCATION: The Westin Alexandria, 400 Courthouse Square, Alexandria, VA 22314 CLOSEST AIRPORT: Reagan National (4.5 miles from the PAME hotel) DETAILS: PAME is a meeting of parents and adults with epilepsy, advocates, researchers and doctors to advance dialogue and find solutions for…  Read More

Help Us Improve our Website: Parent, Caregiver, and Advocate Survey

Posted on:

In preparation for the upcoming Child Neurology Foundation (CNF) Board of Directors’ strategic planning meeting, we kindly request a few minutes of your time to complete a CNF website survey. This survey is designed specifically for parents, caregivers, and advocates and is intended to provide valuable data that will assist us…  Read More

The Epilepsy Foundation: Knowledge about Epilepsy and Risk Factors Survey

Posted on:

The Epilepsy Foundation is constantly enhancing epilepsy.com. To help, they are asking users for a better understanding of what they know about the impact of epilepsy and seizures. Your answers to this survey will help us build a better website to help you manage your seizures. They welcome participation from…  Read More

The Epilepsy Foundation SUDEP Institute will be awarding more than $1 million to address Sudden Unexpected Death in Epilepsy (SUDEP)

Posted on:

The Epilepsy Foundation SUDEP Institute will be awarding more than $1 million for a series of four prize challenge competitions working to address Sudden Unexpected Death in Epilepsy (SUDEP). These challenges allow us to take advantage of interdisciplinary approaches and alternative perspectives. Through combining and contrasting ideas, the best and…  Read More

UMDF Great Lakes Regional Mitochondrial Medicine Symposium

Posted on:

Clinical/Medical Sessions (CME) Friday, May 20, 2016 Patient/Family Sessions (non CME) Saturday, May 21, 2016 To view schedule and speakers – visit www.umdf.org/GreatLakesClinicalAgenda. Complete symposium details, including the family agenda, course description, faculty disclosures, and registration are available at www.umdf.org/symposium/greatlakes. CME CREDIT This activity has been planned and implemented in…  Read More

Eisai Announces FDA Approval of FYCOMPA® (perampanel) Oral Suspension for Adjunctive Therapy in the Treatment of Partial-Onset Seizures and Primary Generalized Tonic-Clonic Seizures

Posted on:

New Formulation Expands Treatment Options for Epilepsy Patients with POS and PGTC Seizures Woodcliff Lake, NJ, May 2, 2016 – Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved FYCOMPA® (perampanel) CIII Oral Suspension as adjunctive therapy for the treatment of partial-onset seizures (POS) with…  Read More

MENU